Schedule 13G ownership disclosure

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Security class unavailable · CUSIP: 539319103

Event date: 2017-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-17-001338
Form type
SC 13G
Filer
ANTEBI STEVEN
CIK
CIK 1086470
Filed
Feb 14, 2017
Reporting period
Jan 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub